Bausch & Lomb (BLCO) Amortization of Deferred Charges (2022 - 2026)
Bausch & Lomb (BLCO) posted Amortization of Deferred Charges of $3.0 million for Q1 2026, down 25.0% on a QoQ basis from $4.0 million in Q4 2025, and down 40.0% year-over-year from $5.0 million in Q1 2025.
Bausch & Lomb (BLCO) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Bausch & Lomb's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 40.0% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.0 million (down 20.0% YoY) and the FY2025 annual result came in at $18.0 million, down 10.0% from the prior year.
- Amortization of Deferred Charges was $3.0 million for Q1 2026 at Bausch & Lomb, down from $4.0 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $19.0 million in Q3 2023 and bottomed at $2.0 million in Q2 2022.
- A 5-year average of $4.9 million and a median of $4.5 million in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges jumped 533.33% — and 2024, when it slumped 73.68%.
- Bausch & Lomb's Amortization of Deferred Charges stood at $3.0 million in 2022, then surged by 66.67% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then declined by 20.0% to $4.0 million in 2025, then slipped by 25.0% to $3.0 million in 2026.
- Business Quant data shows BLCO's Amortization of Deferred Charges at $3.0 million in Q1 2026, $4.0 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |